OnKure Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
OnKure Therapeutics Current Ratio Growth & History (OKUR)
OnKure Therapeutics's current ratio was 10.28 for fiscal 2025.
View full OnKure Therapeutics company overviewOnKure Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 10.28 | −0.46 | −4.25% |
| 2024 | 2024-12-31 | 10.73 | 6.10 | +131.53% |
| 2023 | 2023-12-31 | 4.64 | −10.29 | −68.95% |
| 2022 | 2022-12-31 | 14.93 | −9.86 | −39.77% |
| 2021 | 2021-12-31 | 24.79 | 12.77 | +106.32% |
| 2020 | 2020-12-31 | 12.01 | — | — |
OnKure Therapeutics quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 26.75 | 15.62 | +140.32% |
| Q1 2026 | 2026-03-31 | 13.78 | 2.61 | +23.33% |
| Q4 2025 | 2025-12-31 | 10.28 | −0.46 | −4.25% |
| Q3 2025 | 2025-09-30 | 11.45 | −12.26 | −51.70% |
| Q2 2025 | 2025-06-30 | 11.13 | −46.73 | −80.76% |
| Q1 2025 | 2025-03-31 | 11.17 | −18.65 | −62.53% |
| Q4 2024 | 2024-12-31 | 10.73 | 6.10 | +131.53% |
| Q3 2024 | 2024-09-30 | 23.71 | 14.21 | +149.69% |
| Q2 2024 | 2024-06-30 | 57.86 | 47.21 | +443.21% |
| Q1 2024 | 2024-03-31 | 29.82 | 20.57 | +222.20% |
| Q4 2023 | 2023-12-31 | 4.64 | −10.29 | −68.95% |
| Q3 2023 | 2023-09-30 | 9.49 | −3.31 | −25.85% |
| Q2 2023 | 2023-06-30 | 10.65 | −5.19 | −32.75% |
| Q1 2023 | 2023-03-31 | 9.26 | −8.79 | −48.70% |
| Q4 2022 | 2022-12-31 | 14.93 | −9.86 | −39.77% |
| Q3 2022 | 2022-09-30 | 12.80 | −12.80 | −49.99% |
| Q2 2022 | 2022-06-30 | 15.84 | −35.46 | −69.13% |
| Q1 2022 | 2022-03-31 | 18.04 | −5.76 | −24.21% |
| Q4 2021 | 2021-12-31 | 24.79 | 12.77 | +106.32% |
| Q3 2021 | 2021-09-30 | 25.60 | — | — |
| Q2 2021 | 2021-06-30 | 51.30 | — | — |
| Q1 2021 | 2021-03-31 | 23.81 | — | — |
| Q4 2020 | 2020-12-31 | 12.01 | — | — |
OnKure Therapeutics current ratio trends
Over the last five fiscal years, OnKure Therapeutics's current ratio decreased from 12.01 to 10.28, a change of −1.74. The latest reported quarter, Q2 2026, shows 26.75.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OnKure Therapeutics source filings ↗